Use of Traditional and Biventricular Implantable Cardiac Devices for Primary and Secondary Prevention of Sudden Death

2008 ◽  
Vol 26 (3) ◽  
pp. 419-431 ◽  
Author(s):  
Matthew H. Klein ◽  
Michael R. Gold
Author(s):  
Louisa O’Neill ◽  
Iain Sim ◽  
John Whitaker ◽  
Steven Williams ◽  
Henry Chubb ◽  
...  

Electrophysiology is one of the most rapidly growing area of cardiology. Currently >50,000 catheter ablations are performed in Europe every year and >200,000 patients receive a device for arrhythmia treatment, sudden death prevention, or cardiac resynchronization. The advantages and limitations of fluoroscopy are well known. The rapid development of implantable cardiac devices therapies and ablation procedures all depend on accurate and reliable imaging modalities for preprocedural assessments, intraprocedural guidance, detection of complications, and post-procedural assessment for the longitudinal follow-up of patients. Therefore, over the last decades, imaging become an integral part of electrophysiological procedures.


2014 ◽  
Vol 33 (2) ◽  
pp. 166-169
Author(s):  
Tomislav Kostić ◽  
Zoran Perišić ◽  
Aleksandar Stojković ◽  
Predrag Cvetković ◽  
Mirko Krstić ◽  
...  

EP Europace ◽  
2003 ◽  
Vol 4 (Supplement_2) ◽  
pp. B179-B179
Author(s):  
M. Zecchin ◽  
A. Di Lenarda ◽  
E. Petz ◽  
G. Sabbadini ◽  
G. Sinagra ◽  
...  

EP Europace ◽  
2003 ◽  
Vol 4 (Supplement_1) ◽  
pp. A22-A22
Author(s):  
M. Zecchin ◽  
A. Di Lenarda ◽  
G. Faganello ◽  
E. Petz ◽  
D. Facchin ◽  
...  

2010 ◽  
Vol 6 (3) ◽  
pp. 87
Author(s):  
Niraj Varma ◽  

The use of implantable electronic cardiac devices is increasing. Post-implantation follow-up is important for monitoring both device function and patient condition; however, clinical practice is inconsistent. For example, implantable cardioverter–defibrillator follow-up schedules vary from every three months to yearly according to facility and physician preference and the availability of resources. Importantly, no surveillance occurs between follow-up visits. By contrast, implantable devices with automatic remote monitoring capability provide a means for performing constant surveillance, with the ability to identify salient problems rapidly. The Lumos-T Reduces Routine Office Device Follow-up Study (TRUST) demonstrated that remote home monitoring reduced clinic burden and allowed early detection of patient and/or system problems, enabling efficient monitoring and an opportunity to enhance patient safety. The results of the trial have significant implications for the management of patients receiving all forms of implantable electronic cardiac device.


Sign in / Sign up

Export Citation Format

Share Document